Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.24 - $1.2 $105,226 - $526,130
-438,442 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.94 - $2.38 $1.61 Million - $4.08 Million
-1,712,746 Reduced 79.62%
438,442 $526,000
Q4 2021

Feb 11, 2022

BUY
$1.89 - $3.12 $11,137 - $18,386
5,893 Added 0.27%
2,151,188 $5.57 Million
Q3 2021

Nov 12, 2021

SELL
$2.34 - $3.77 $3.05 Million - $4.91 Million
-1,303,164 Reduced 37.79%
2,145,295 $5.02 Million
Q2 2021

Aug 12, 2021

BUY
$3.48 - $4.45 $532,147 - $680,476
152,916 Added 4.64%
3,448,459 $12.6 Million
Q1 2021

May 11, 2021

BUY
$3.57 - $6.2 $114,004 - $197,990
31,934 Added 0.98%
3,295,543 $12.1 Million
Q4 2020

Feb 10, 2021

BUY
$4.4 - $7.32 $2.5 Million - $4.16 Million
567,887 Added 21.07%
3,263,609 $17 Million
Q3 2020

Nov 12, 2020

BUY
$4.38 - $8.35 $5.88 Million - $11.2 Million
1,343,287 Added 99.32%
2,695,722 $13.9 Million
Q2 2020

Aug 12, 2020

BUY
$3.64 - $9.26 $66,888 - $170,161
18,376 Added 1.38%
1,352,435 $10 Million
Q1 2020

May 12, 2020

BUY
$2.54 - $9.38 $176,410 - $651,469
69,453 Added 5.49%
1,334,059 $5.27 Million
Q4 2019

Feb 12, 2020

BUY
$7.07 - $9.51 $3.04 Million - $4.09 Million
429,705 Added 51.47%
1,264,606 $12 Million
Q3 2019

Nov 12, 2019

BUY
$7.77 - $11.26 $648,181 - $939,320
83,421 Added 11.1%
834,901 $6.49 Million
Q2 2019

Aug 09, 2019

BUY
$7.91 - $10.25 $3.01 Million - $3.9 Million
380,606 Added 102.62%
751,480 $7.03 Million
Q1 2019

May 10, 2019

BUY
$6.0 - $11.07 $2.23 Million - $4.11 Million
370,874 New
370,874 $3.34 Million

Others Institutions Holding QTNT

# of Institutions
1
Shares Held
1.71K
Call Options Held
0
Put Options Held
0

About Quotient Ltd


  • Ticker QTNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Description
  • Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...
More about QTNT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.